Sally L. Shirran

1.8k citations

54 papers · 1.3k indexed · h-index 20

Pharmacology top 2%
- Microbial Natural Products and Biosynthesis 5
Molecular Biology top 10%
- RNA modifications and cancer 6
- RNA Research and Splicing 5
- RNA and protein synthesis mechanisms 4
- Cancer-related gene regulation 3
Biotechnology top 10%
Process Chemistry and Technology
Pediatrics, Perinatology and Child Health top 10%
Genetics
- Neurogenetic and Muscular Disorders Research 5
Immunology
- Immunotherapy and Immune Responses 4
Spectroscopy
- Mass Spectrometry Techniques and Applications 3

Co-authors: Catherine H. Botting James H. Naismith Jesko Koehnke Wael E. Houssen Marcel Jaspars Andrew F. Bent Greg Mann Perdita E. Barran
Cited by: Pharmacology Molecular Biology Biotechnology
Journals: Nature (1 paper)Proceedings of the National Academy of Sciences (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Sally L. Shirran

54 papers receiving 1.3k citations

Peers

Countries citing papers authored by Sally L. Shirran

Since Specialization

Citations

This map shows the geographic impact of Sally L. Shirran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally L. Shirran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally L. Shirran more than expected).

Fields of papers citing papers by Sally L. Shirran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally L. Shirran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally L. Shirran. The network helps show where Sally L. Shirran may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sally L. Shirran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sally L. Shirran Line = papers co-authored together Sally L. Shirran links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cryo-EM structure of the conjugation H-pilus reveals the cyclic nature of the TrhA pilin Proceedings of the National Academy of Sciences ·Naito Ishimoto,Joshua L. C. Wong,Shan He,Sally L. Shirran,Olivia Wright-Paramio,Chloe Seddon,Nanki Singh,Carlos Balsalobre,Ravi R. Sonani,Abigail Clements,Edward H. Egelman,Gad Frankel,Konstantinos Beis	2025	1
2	Proteomic characterization of human LMNA-related congenital muscular dystrophy muscle cells Neuromuscular Disorders ·Emily C Storey,Ian Holt,Sharon J. Brown,Silvia A. Synowsky,Sally L. Shirran,Heidi R. Fuller	2024	2
3	Antiviral type III CRISPR signalling via conjugation of ATP and SAM Nature ·Haotian Chi,Ville Hoikkala,Sabine Grüschow,Shirley Graham,Sally L. Shirran,Malcolm F. White	2023	26
4	Unusual peptide-binding proteins guide pyrroloindoline alkaloid formation in crocagin biosynthesis Nature Chemistry ·Sebastian Adam,Dazhong Zheng,Andreas Klein,Carsten Volz,William Mullen,Sally L. Shirran,Brian O. Smith,Olga V. Kalinina,Rolf Müller,Jesko Koehnke	2023	19
5	Carbapenem-Only Combination Therapy against Multi-Drug Resistant Pseudomonas aeruginosa: Assessment of In Vitro and In Vivo Efficacy and Mode of Action Antibiotics ·Brendan J. MacKay,Benjamin J. Parcell,Sally L. Shirran,Peter J. Coote	2022	1
6	Tumour‐associated antigenic peptides are present in the HLA class I ligandome of cancer cell line derived extracellular vesicles Immunology ·Pankaj Kumar,Caitlin Boyne,Sydney Brown,Ayesha Qureshi,Peter Thorpe,Silvia A. Synowsky,Sally L. Shirran,Simon J. Powis	2022	10
7	The Proteome Signatures of Fibroblasts from Patients with Severe, Intermediate and Mild Spinal Muscular Atrophy Show Limited Overlap Cells ·Sharon J. Brown,Rachel Kline,Silvia A. Synowsky,Sally L. Shirran,Ian Holt,Kelly A. Sillence,Peter Claus,Brunhilde Wirth,Thomas M. Wishart,Heidi R. Fuller	2022	6
8	Identification of plasma proteins associated with oesophageal cancer chemotherapeutic treatment outcomes using SWATH-MS Journal of Proteomics ·Naici Guo,Giorgos Minas,Silvia A. Synowsky,Margaret R. Dunne,Hasnain Ahmed,Rhiannon McShane,Anshul Bhardwaj,Noel E. Donlon,Cliona Lorton,Jacintha O’Sullivan,John V. Reynolds,Peter D. Caie,Sally L. Shirran,Andy G. Lynch,Alan J. Stewart,Swati Arya	2022	3
9	Quantitative proteomic profiling of the rat substantia nigra places glial fibrillary acidic protein at the hub of proteins dysregulated during aging: Implications for idiopathic Parkinson's disease Journal of Neuroscience Research ·Yolanda Gómez‐Gálvez,Heidi R. Fuller,Silvia A. Synowsky,Sally L. Shirran,Monte Gates	2020	5
10	Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development JCI Insight ·Johannes Beiersdorf,Zsófia Hevesi,Daniela Calvigioni,Jakob Pyszkowski,Roman A. Romanov,Edit Szodorai,Gert Lübec,Sally L. Shirran,Catherine H. Botting,Siegfried Kasper,Geoffrey W. Guy,Roy Gray,Vincenzo Di Marzo,Tibor Harkany,Erik Keimpema	2020	15
11	Neurochondrin interacts with the SMN protein suggesting a novel mechanism for spinal muscular atrophy pathology Journal of Cell Science ·Luke Thompson,Kim D. Morrison,Sally L. Shirran,Ewout J. N. Groen,Thomas H. Gillingwater,Catherine H. Botting,Judith Sleeman	2018	12
12	Two independent proteomic approaches provide a comprehensive analysis of the synovial fluid proteome response to Autologous Chondrocyte Implantation Arthritis Research & Therapy ·Charlotte Hulme,E. Lynette Wilson,Heidi R. Fuller,Sally Roberts,James B. Richardson,Pete Gallacher,Mandy J. Peffers,Sally L. Shirran,Catherine H. Botting,Karina T. Wright	2018	6
13	hSSB1 phosphorylation is dynamically regulated by DNA-PK and PPP-family protein phosphatases DNA repair ·Nicholas W. Ashton,Nicolas Paquet,Sally L. Shirran,Emma Bolderson,Ruvini Kariawasam,Christine Touma,Azadeh Fallahbaghery,Roland Gamsjaeger,Liza Cubeddu,Catherine H. Botting,Pamela M. Pollock,Kenneth J. O’Byrne,Derek J. Richard	2017	14
14	Contaminants in commercial preparations of ‘purified’ small leucine-rich proteoglycans may distort mechanistic studies Bioscience Reports ·Sharon J. Brown,Heidi R. Fuller,Philip R. Jones,Bruce Caterson,Sally L. Shirran,Catherine H. Botting,Sally Roberts	2016	2
15	Spinal Muscular Atrophy Patient iPSC-Derived Motor Neurons Have Reduced Expression of Proteins Important in Neuronal Development Frontiers in Cellular Neuroscience ·Heidi R. Fuller,Berhan Mandefro,Sally L. Shirran,Andrew Gross,Anjoscha S. Kaus,Catherine H. Botting,Glenn E. Morris,Dhruv Sareen	2016	55
16	Miswiring the brain: 9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway The EMBO Journal ·Giuseppe Tortoriello,Caroline Morris,Alán Alpár,János Fuzik,Sally L. Shirran,Daniela Calvigioni,Erik Keimpema,Catherine H. Botting,Kirstin Reinecke,Thomas Herdegen,Michael J. Courtney,Yasmin L. Hurd,Tibor Harkany	2014	174
17	Kdm3a lysine demethylase is an Hsp90 client required for cytoskeletal rearrangements during spermatogenesis Molecular Biology of the Cell ·Ioannis Kasioulis,Heather M. Syred,Peri Tate,Andrew J. Finch,Joseph Shaw,Anne Seawright,Matt Fuszard,Catherine H. Botting,Sally L. Shirran,Ian R. Adams,Ian J. Jackson,Veronica van Heyningen,Patricia L. Yeyati	2014	30
18	The Cyanobactin Heterocyclase Enzyme: A Processive Adenylase That Operates with a Defined Order of Reaction Angewandte Chemie ·Jesko Koehnke,Andrew F. Bent,David Zollman,Kieran Smith,Wael E. Houssen,Xiaofeng Zhu,Greg Mann,Tomáš Lébl,Richard Scharff,Sally L. Shirran,Catherine H. Botting,Marcel Jaspars,Ulrich Schwarz‐Linek,James H. Naismith	2013	15
19	An Enzymatic Route to Selenazolines ChemBioChem ·Jesko Koehnke,Falk Morawitz,Andrew F. Bent,Wael E. Houssen,Sally L. Shirran,Matthew Fuszard,Iain A. Smellie,Catherine H. Botting,Margaret C. M. Smith,Marcel Jaspars,James H. Naismith	2013	23
20	A comparison of the accuracy of iTRAQ quantification by nLC-ESI MSMS and nLC-MALDI MSMS methods Journal of Proteomics ·Sally L. Shirran,Catherine H. Botting	2010	51

About Sally L. Shirran

Sally L. Shirran is a scholar working on Equine, Pharmacology and Molecular Biology, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Microbial Natural Products and Biosynthesis (5 papers), Neurogenetic and Muscular Disorders Research (5 papers), RNA Research and Splicing (5 papers), Immunotherapy and Immune Responses (4 papers), RNA and protein synthesis mechanisms (4 papers), Mass Spectrometry Techniques and Applications (3 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Pharmacology (469 citations), Molecular Biology (800 citations) and Biotechnology (81 citations). Sally L. Shirran has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Catherine H. Botting, James H. Naismith, Jesko Koehnke, Wael E. Houssen, Marcel Jaspars, Andrew F. Bent, Greg Mann, Perdita E. Barran, Tomáš Lébl and Tibor Harkany. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact